The global antiviral drugs market is expected to grow steadily through 2032, driven by rising prevalence of chronic viral infections like HIV, hepatitis, influenza, and emerging threats. Demand for branded antivirals remains high, while generics are gaining share in emerging regions. Key growth factors include personalized medicine, AI/ML drug discovery platforms, combination therapie... https://www.uniprismmarketresearch.com/verticals/healthcare/antiviral-drugs